Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 15, 2011

Protagen and instrAction to Develop Customized Separation Phases

  • Protagen and instrAction are joining forces to develop customized chromatography phases for downstream processing based on the latter's technology. Protagen will contribute its expertise in GMP-compliant protein analysis and related services to develop a portfolio of new tailor-made separation phases for the production of recombinant protein drugs other biotherapeutics and biosimilars.

    instrAction develops and manufactures instrAction® phases, highly selective resins for chromatography. The technology allows for immobilization of small molecules as well as substances with high molecular weight on a polymer network coated on different porous backbone materials.

    “In order to exploit the full value of this exciting new protein purification technology and to convince customers from pharma process development and production, it is important to provide convincing data sets from feasibility studies,” states Stefan Müllner, CEO of Protagen.

    Protagen, which also specializes in in vitro diagnostics, has raised a total €10 million ($13.9 million) in two financing rounds, the second one closing in September. On February 7, instrAction announced it expanded an alliance formed in July with Novasep beyond nonchiral chromatography to include the purification of taxanes.




Related content


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Pharmacists and Prescription Drug Misuse Programs

Do you agree that pharmacists should make a greater effort to become more involved with prescription drug-monitoring programs?

More »